Coherus BioSciences entered into a loan agreement with investment funds managed by Pharmakon Advisors, LP.“As Coherus enters a period of projected significant topline growth and diversification of our commercial product portfolio, we are pleased to...
Read Story
January 10, 2022, 07:07 AM
|
Evolus, a performance beauty company, entered into a $125 million term loan financing facility with funds managed by Pharmakon Advisors, L.P.The term loan facility will be available to Evolus under the following terms:
A senior secured term loan...
Read Story
December 15, 2021, 07:45 AM
|
Depomed, Inc. has entered into a definitive agreement with Deerfield and Pharmakon Advisors, LP to borrow $575 million. The proceeds of the loan will be used to fund the acquisition of the U.S. rights to the NUCYNTA franchise from Janssen...
Read Story
March 13, 2015, 07:21 AM
|